Current HER2 assessment models for breast cancer typically focus on analyzing H&E or IHC images separately despite the clinical need for their combined interpretation.
Proposed adaptive bimodal framework enables flexible HER2 prediction using single- or dual-modality inputs via dynamic branch selection.
Innovations include a branch selector for single- or dual-modality prediction, a bidirectional GAN for context-aware reconstruction, and a hybrid training protocol.
Framework boosts H&E prediction accuracy from 71.44% to 94.25% and achieves 95.09% accuracy for dual-modality prediction, maintaining 90.28% reliability with only IHC inputs.
Design allows for near-bimodal performance without synchronized acquisition, aiding resource-limited settings through reduced IHC costs.
Experimental validation shows 22.81%/12.90% accuracy improvements over baseline models, with enhanced F1-scores for cross-modal reconstructions.
System dynamically routes inputs for reconstruction or fusion pathways, mitigating performance issues from missing data while maintaining computational efficiency.
The architecture demonstrates potential for widespread use in precise HER2 assessment across various healthcare environments.